Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review
- PMID: 28620541
- PMCID: PMC5424400
- DOI: 10.1186/s40738-016-0029-2
Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review
Abstract
Background: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with an estimated prevalence of 4-21% in reproductive aged women. The altered metabolic and hormonal environment among women with PCOS may increase their risk of some types of cancer.
Methods: We performed a comprehensive review of the literature using numerous search terms for all studies examining the associations between polycystic ovary syndrome and related characteristics and cancer published in English through October 2016. This review summarizes the epidemiological findings on the associations between PCOS and endometrial, ovarian, and breast cancers and discusses the methodological issues, complexities, and underlying mechanisms of these associations.
Results: We identified 11 individual studies and 3 meta-analyses on the associations between PCOS and endometrial cancer, 8 studies and 1 meta-analysis for ovarian cancer, and 10 studies and 1 meta-analysis for breast cancer. Multiple studies reported that women with PCOS were at a higher risk for endometrial cancer; however, many did not take into account body mass index (BMI), a strong and well-established risk factor for endometrial cancer. The association with ovarian cancer was less clear, but a potentially increased risk of the borderline serous subtype was reported by two studies. No consistent association between PCOS risk and breast cancer was observed.
Conclusion: The associations between PCOS and endometrial, ovarian, and breast cancer are complex, with the need to consider many methodological issues in future analyses. Larger well-designed studies, or pooled analyses, may help clarify these complex associations.
Keywords: Breast cancer; Endometrial cancer; Ovarian cancer; Polycystic ovary syndrome.
Similar articles
-
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod Update. 2014 Sep-Oct;20(5):748-58. doi: 10.1093/humupd/dmu012. Epub 2014 Mar 30. Hum Reprod Update. 2014. PMID: 24688118 Free PMC article. Review.
-
Risk of endometrial, ovarian, and breast cancers in women with polycystic ovary syndrome: A systematic review and meta-analysis.Int J Reprod Biomed. 2022 Dec 10;20(11):893-914. doi: 10.18502/ijrm.v20i11.12357. eCollection 2022 Nov. Int J Reprod Biomed. 2022. PMID: 36618838 Free PMC article. Review.
-
Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis.Scott Med J. 2022 Aug;67(3):109-120. doi: 10.1177/00369330221107099. Epub 2022 Jun 9. Scott Med J. 2022. PMID: 35686317
-
Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association.Cureus. 2023 Apr 7;15(4):e37266. doi: 10.7759/cureus.37266. eCollection 2023 Apr. Cureus. 2023. PMID: 37162768 Free PMC article. Review.
-
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044. Hum Reprod. 2017. PMID: 28333286 Review.
Cited by
-
The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis.Cancer Cell Int. 2022 Mar 19;22(1):125. doi: 10.1186/s12935-022-02547-5. Cancer Cell Int. 2022. PMID: 35305643 Free PMC article. Review.
-
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):174-182. doi: 10.1158/1055-9965.EPI-17-0655. Epub 2017 Nov 15. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29141849 Free PMC article.
-
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis.Front Endocrinol (Lausanne). 2020 Oct 26;11:585130. doi: 10.3389/fendo.2020.585130. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33329391 Free PMC article. Review.
-
Inflammatory Responses of Women with Polycystic Ovary Syndrome in Vitro Differ from Healthy Women.Int J Mol Cell Med. 2023;12(1):70-80. doi: 10.22088/IJMCM.BUMS.12.1.70. Int J Mol Cell Med. 2023. PMID: 37942263 Free PMC article.
-
Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations.Life (Basel). 2022 Nov 25;12(12):1974. doi: 10.3390/life12121974. Life (Basel). 2022. PMID: 36556340 Free PMC article. Review.
References
-
- Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol. 2011;62:238–242. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources